Physician profile
Aswini Kumar
NPI 1619318029
$1,152.95
in general payments reported to CMS, 2019-2025
17 companies · $149 in 2025
The $149 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $556 · 2020: $79.09 · 2021: $14.14 · 2022: $217 · 2023: $41.16 · 2024: $95.56 · 2025: $149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $286.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $286.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $188.93 | 2019-2022 | |
| Abbott Laboratories | $150.32 | 2019-2020 | |
| Edwards Lifesciences Corporation | $138.04 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $132.21 | 2019 | |
| Astellas Pharma US INC | $89.99 | 2019 | |
| Medtronic, INC. | $89.99 | 2023-2025 | Cobalt Dr Mri Surescan, Micra, Linq II |
| Novartis Pharmaceuticals Corporation | $68.23 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $58.54 | 2019-2025 | Lifevest |
| Kestra Medical Technology Services, INC. | $54.62 | 2024-2025 | Assure Wcd |
| Boston Scientific Corporation | $54.55 | 2019-2024 | Angiojet Ultra 5000a |
| Philips North America LLC | $30.66 | 2023-2025 | Extended Holter |
| Sanofi-Aventis U.S. LLC | $21.24 | 2019 | |
| Cardiva Medical, INC. | $18.34 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $14.76 | 2024 | Farxiga |
| Pfizer INC. | $14.36 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $14.14 | 2021 | |
| Merck Sharp & Dohme LLC | $14.03 | 2025 | Verquvo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aswini Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.